Table 4.

Multiple stepwise logistic regression of target organ damage in different groups.

Variance		β	SE	Exp β	95% CI	P value
CIMT abnormality	Age	0.085	0.008	1.088	1.071–1.106	<0.001
	Sex	−0.714	0.188	0.490	0.339–0.709	<0.001
	BMI	−0.050	0.024	0.951	0.907–0.997	0.037
	Antihypertensive drugs (yes or no)	0.644	0.174	1.905	1.354–2.680	<0.001
	FBG	0.128	0.056	1.137	1.019–1.267	0.021
LVH	Age	0.047	0.008	1.048	1.032–1.064	<0.001
	Sex	0.949	0.187	2.582	1.789–3.728	<0.001
	BMI	0.050	0.023	1.051	1.004–1.100	0.033
	Antihypertensive drugs (yes or no)	0.362	0.171	1.437	1.028–2.007	0.034
	HDL-c	−0.719	0.324	0.487	0.258–0.920	0.027
	HR	−0.023	0.009	0.978	0.961–0.995	0.010
	Group (control) (Ref)					0.001
	Group (cfPWV/CBP)	0.566	0.306	1.762	0.967–3.209	0.064
	Group (cfPWV)	0.878	0.314	2.406	1.301–4.452	0.005
	Group (CBP)	0.696	0.208	2.007	1.335–3.017	0.001
CKD	Age	0.072	0.016	1.074	1.040–1.109	<0.001
ACR abnormality	Antihypertensive drugs (yes or no)	0.826	0.220	2.284	1.485–3.513	<0.001
	FBG	0.147	0.049	1.159	1.052–1.276	0.003
	Group (control) (Ref)					<0.001
	Group (cfPWV/CBP)	1.169	0.347	3.219	1.630–6.359	0.001
	Group (cfPWV)	0.258	0.388	1.294	0.605–2.767	0.507
	Group (CBP)	1.149	0.243	3.156	1.961–5.079	<0.001

All variables adjusted for age, sex (male or female), height, BMI, body mass index, smoking history, antihypertensive drugs (yes or no), HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; FBG, fasting blood glucose; pMAP, peripheral mean arterial pressure; HR, heart rate beats per minute; VIF, variance inflation factor.

The bold values represent the values that are statistically significant (P < 0.05).